Related Experiment Video
Updated: Jan 10, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Liposomal bupivacaine: a delay rather than elimination of rebound pain in mouse postoperative model
1Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, China.
Background:
Liposomal bupivacaine (LB) provides prolonged analgesia, but it remains unclear whether it prevents rebound pain or merely delays its onset. This study investigated the effect of LB on rebound pain in a mouse model of peripheral nerve block to determine whether its resolution results in a pain response exceeding that of unblocked controls.
Methods:
Methylene blue staining was employed to compare the success rate of nerve stimulator-guided versus anatomical landmark-based techniques for combined sciatic and femoral nerve blockade.Postoperative rebound pain following liposomal bupivacaine administration under nerve stimulator guidance was assessed at multiple time points using von Frey and Hargreaves tests. Histological analyses of perineural inflammation and Wallerian degeneration were conducted on postoperative days 2 and 28.
Results:
Nerve stimulator-guided blocks had high success rates (sciatic: 93.3%, P=0.035; femoral: 73.3%, P=0.030).LB extended thermal (24h, P<0.05) and mechanical (36h, P<0.05) analgesia. Transient thermal rebound pain occurred at 48h (P=0.003), but no mechanical rebound was observed. LB group showed significantly more severe Wallerian degeneration and Neural inflammation in both the sciatic and femoral nerves compared to the S group at day 2 (P<0.05).
Conclusions:
Liposomal bupivacaine did not prevent rebound pain but merely delayed its onset in a mouse model of combined sciatic and femoral nerve block.
Insights
Liposomal bupivacaine (LB) delays, but does not prevent, rebound pain after nerve blocks. This study found LB extended analgesia but caused delayed pain and increased nerve inflammation in mice.
Area of Science:
- Anesthesiology
- Pain Management
- Pharmacology
Background:
- Prolonged analgesia with liposomal bupivacaine (LB) is established, but its effect on rebound pain remains unclear.
- This study investigates if LB prevents or merely delays rebound pain following peripheral nerve blockade.
Purpose of the Study:
- To determine the effect of LB on rebound pain in a mouse model.
- To assess if nerve block resolution with LB results in pain exceeding unblocked controls.
Main Methods:
- Nerve stimulator-guided vs. landmark-based sciatic and femoral nerve blockade success rates were compared using methylene blue staining.
- Rebound pain after LB administration was assessed using von Frey and Hargreaves tests.
- Histological analyses examined perineural inflammation and Wallerian degeneration.
Main Results:
- Nerve stimulator guidance demonstrated high block success rates (93.3% sciatic, 73.3% femoral).
- LB extended thermal (24h) and mechanical (36h) analgesia.
- Transient thermal rebound pain occurred at 48h; no mechanical rebound was observed. Increased Wallerian degeneration and nerve inflammation were noted in the LB group.
Conclusions:
- Liposomal bupivacaine delays the onset of rebound pain rather than preventing it.
- LB administration in a mouse model resulted in delayed pain and increased nerve inflammation.
Related Concept Videos
Local Anesthetics: Pharmacokinetics
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Local Anesthetics: Clinical Application as Spinal Anesthesia
Analgesia and Pain Management

